DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Boehringer Ingelheim Pharma GmbH & Co. KG. RE-SPECT CVT.
a randomised, open-label, exploratory trial with blinded endpoint adjudication (PROBE), comparing efficacy and safety of oral dabigatran etexilate versus oral warfarin in patients with cerebral venous and dural sinus thrombosis over a 24-wee [Internet].
EudraCT. Nr. 2015-004412-382017; [cited 2017 Jun 5] Available from:
https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004412-38/DE
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.